Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review
- PMID: 24331453
- DOI: 10.1016/j.amjmed.2013.09.017
Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review
Abstract
Background: There is accumulating evidence that restricting blood transfusions improves outcomes, with newer trials showing greater benefit from more restrictive strategies. We systematically evaluated the impact of various transfusion triggers on clinical outcomes.
Methods: The MEDLINE database was searched from 1966 to April 2013 to find randomized trials evaluating a restrictive hemoglobin transfusion trigger of <7 g/dL, compared with a more liberal trigger. Two investigators independently extracted data from the trials. Outcomes evaluated included mortality, acute coronary syndrome, pulmonary edema, infections, rebleeding, number of patients transfused, and units of blood transfused per patient. Extracted data also included information on study setting, design, participant characteristics, and risk for bias of the included trials. A secondary analysis evaluated trials using less restrictive transfusion triggers, and a systematic review of observational studies evaluated more restrictive triggers.
Results: In the primary analysis, pooled results from 3 trials with 2364 participants showed that a restrictive hemoglobin transfusion trigger of <7 g/dL resulted in reduced in-hospital mortality (risk ratio [RR], 0.74; confidence interval [CI], 0.60-0.92), total mortality (RR, 0.80; CI, 0.65-0.98), rebleeding (RR, 0.64; CI, 0.45-0.90), acute coronary syndrome (RR, 0.44; CI, 0.22-0.89), pulmonary edema (RR, 0.48; CI, 0.33-0.72), and bacterial infections (RR, 0.86; CI, 0.73-1.00), compared with a more liberal strategy. The number needed to treat with a restrictive strategy to prevent 1 death was 33. Pooled data from randomized trials with less restrictive transfusion strategies showed no significant effect on outcomes.
Conclusions: In patients with critical illness or bleed, restricting blood transfusions by using a hemoglobin trigger of <7 g/dL significantly reduces cardiac events, rebleeding, bacterial infections, and total mortality. A less restrictive transfusion strategy was not effective.
Keywords: Clinical outcomes; Meta-analysis; Mortality; Systematic review; Transfusion.
Copyright © 2014 Elsevier Inc. All rights reserved.
Comment in
-
Should we universally adopt a restrictive approach to blood transfusion? It's all about the number.Am J Med. 2014 Feb;127(2):103-4. doi: 10.1016/j.amjmed.2013.10.026. Epub 2013 Nov 21. Am J Med. 2014. PMID: 24269656 No abstract available.
-
Leucoreduction of blood components: an effective way to increase blood safety?Blood Transfus. 2016 May;14(2):214-27. doi: 10.2450/2015.0154-15. Epub 2015 Dec 16. Blood Transfus. 2016. PMID: 26710353 Free PMC article. Review.
Similar articles
-
Benefits and harms of red blood cell transfusions in patients with septic shock in the intensive care unit.Dan Med J. 2016 Feb;63(2):B5209. Dan Med J. 2016. PMID: 26836806 Review.
-
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.Cochrane Database Syst Rev. 2016 Oct 12;10(10):CD002042. doi: 10.1002/14651858.CD002042.pub4. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2021 Dec 21;12:CD002042. doi: 10.1002/14651858.CD002042.pub5. PMID: 27731885 Free PMC article. Updated. Review.
-
Restrictive versus liberal blood transfusion in patients with coronary artery disease: a meta-analysis.Curr Med Res Opin. 2017 Apr;33(4):761-768. doi: 10.1080/03007995.2017.1280010. Epub 2017 Feb 3. Curr Med Res Opin. 2017. PMID: 28067544
-
Outcomes of restrictive versus liberal transfusion strategies in older adults from nine randomised controlled trials: a systematic review and meta-analysis.Lancet Haematol. 2017 Oct;4(10):e465-e474. doi: 10.1016/S2352-3026(17)30141-2. Epub 2017 Sep 11. Lancet Haematol. 2017. PMID: 28919087 Review.
-
Liberal Transfusion versus Restrictive Transfusion and Outcomes in Critically Ill Adults: A Meta-Analysis.Transfus Med Hemother. 2021 Feb;48(1):60-68. doi: 10.1159/000506751. Epub 2020 Mar 20. Transfus Med Hemother. 2021. PMID: 33708053 Free PMC article. Review.
Cited by
-
Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.Cochrane Database Syst Rev. 2024 May 23;5(5):CD011305. doi: 10.1002/14651858.CD011305.pub3. Cochrane Database Syst Rev. 2024. PMID: 38780066 Review.
-
[Evaluation of training in transfusion safety offered to medical students in Morocco].Pan Afr Med J. 2024 Feb 26;47:84. doi: 10.11604/pamj.2024.47.84.35703. eCollection 2024. Pan Afr Med J. 2024. PMID: 38737220 Free PMC article. French.
-
Does red blood cell transfusion affect clinical outcomes in critically ill patients? A report from a large teaching hospital in south Iran.Ann Saudi Med. 2024 Mar-Apr;44(2):84-92. doi: 10.5144/0256-4947.2024.84. Epub 2024 Apr 4. Ann Saudi Med. 2024. PMID: 38615186 Free PMC article.
-
Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management: History and scenario of patient blood management in the world and in Brazil.Hematol Transfus Cell Ther. 2024 Apr;46 Suppl 1(Suppl 1):S1-S4. doi: 10.1016/j.htct.2024.02.008. Epub 2024 Mar 11. Hematol Transfus Cell Ther. 2024. PMID: 38508946 Free PMC article.
-
Is restrictive transfusion sufficient in colorectal cancer surgery? A retrospective study before and during the COVID-19 pandemic in Korea.Ann Coloproctol. 2023 Dec;39(6):493-501. doi: 10.3393/ac.2023.00437.0062. Epub 2023 Dec 28. Ann Coloproctol. 2023. PMID: 38185948 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
